Herb Cross's Net Worth
$1 Million
Who is Herb Cross?
Herb Cross has an estimated net worth of $1 Million. This is based on reported shares across multiple companies, which include NEOFORMA INC, FACET BIOTECH CORP, ARMO BioSciences, Inc., Atreca, Inc., KALOBIOS PHARMACEUTICALS INC, Apexigen, Inc., PDL BIOPHARMA, INC., AFFYMAX INC, and Jasper Therapeutics, Inc..
SEC CIK
Herb Cross's CIK is 0001230721
Past Insider Trading and Trends
2015 was Herb Cross's most active year for acquiring shares with 13 total transactions. Herb Cross's most active month to acquire stocks was the month of December. 2003 was Herb Cross's most active year for disposing of shares, totalling 7 transactions. Herb Cross's most active month to dispose stocks was the month of August. 2012 saw Herb Cross paying a total of $178,750.00 for 100,000 shares, this is the most they've acquired in one year. In 2018 Herb Cross cashed out on 240,658 shares for a total of $10,355,561.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEOFORMA INC No price found
VP Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +59.20% | 5.2K |
—
|
—
| 13.98K |
Mar 23
| |||
Form 4
| -15.81% | -1.65K |
$8.50 | -$14,025.00 | 8.78K |
Scheduled
|
Feb 22
| ||
Form 4
| -5.77% | -500.00 |
$10.00 | -$5,000.00 | 8.16K |
Scheduled
|
Sep 1
| ||
Form 4
| +33.23% | 2.16K |
$5.70 | $12,301.20 | 8.66K |
Jul 30
| |||
Form 4
| +162.50% | 6.5K |
—
|
—
| 10.5K |
Feb 20
| |||
Form 4
| +162.50% | 6.5K |
—
|
—
| 10.5K |
Feb 20
| |||
Form 4
| -38.10% | -4.00K |
$11.06 | -$44,232.40 | 6.5K |
Feb 23
| |||
Form 4
|
—
|
0
|
$8.52 | -$13,006.08 | 4K |
Scheduled
|
Jan 30 - Feb 2
| ||
Form 4
|
—
|
0
|
$12.10 | -$77,244.88 | 4K |
Nov 7 - Nov 10
| |||
Form 4
|
—
|
0
|
$9.20 | -$11,731.62 | 4K |
Scheduled
|
Jul 31 - Aug 1
| ||
| No matching records found | |||||||||
FACET BIOTECH CORP No price found
VP Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.60K |
$27.00 | -$313,254.00 |
0
|
Apr 21
| |||
Form 4
| -31.28% | -5.28K |
$27.00 | -$142,587.00 | 11.6K |
Apr 20
| |||
Form 4
| -7.25% | -1.32K |
$15.68 | -$20,681.92 | 16.88K |
Jan 23
| |||
Form 4
| -1.10% | -202.00 |
$18.03 | -$3,642.06 | 18.2K |
Dec 19
| |||
Form 4
| -6.97% | -1.38K |
$16.34 | -$22,532.86 | 18.4K |
Sep 14
| |||
Form 4
| +29.44% | 4.5K |
—
|
—
| 19.78K |
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
| +3,251.54% | 14.83K |
$6.17 | -$1,462.29 | 15.28K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARMO BioSciences, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Atreca, Inc. (BCEL) Snapshot price: $0.068
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.01% | -5.49K |
$0.95 | -$5,224.72 | 72.82K |
Aug 2
| |||
Form 4
| +126.61% | 43.75K |
—
|
—
| 78.3K |
Feb 9
| |||
Form 4
| -18.12% | -7.65K |
$1.78 | -$13,573.18 | 34.55K |
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
∞
| 42.2K |
—
|
—
| 42.2K |
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KALOBIOS PHARMACEUTICALS INC (HGEN) Snapshot price: $0.011
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||